Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Regulatory News (FUM)

Share Price Information for Futura Medical (FUM)

Share Price is delayed by 15 minutes
Get Live Data
0.546    -0.034 (-5.86%)
Bid:
0.55
Ask:
0.60
Spread: 0.05 (9.091%)
Market Cap: £3.17m
FUM Live PriceLast checked at - London Stock Exchange

Intraday Futura Medical Share Chart

Board Change

31 Mar 2008 07:01

Futura Medical PLC31 March 2008 For immediate release 31 March 2008 Futura Medical Plc ("Futura" or "the Company") Board Changes Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovativeproducts for the consumer healthcare market, is pleased to announce theappointment as a Non-Executive Director of Lisa Arnold, who has extensiveexperience of the investment and healthcare sectors. Lisa, age 45, worked in the investment banking industry from 1984 to 2001,holding senior positions in healthcare at Commerzbank and UBS. Since 2001, Lisahas worked in non-executive and consultancy roles predominantly in the pensions,healthcare and technology sectors. Lisa is currently a Non-Executive Director of the UK's Medicines & HealthcareProducts Regulatory Agency (MHRA), where she chairs the Risk and AuditCommittee, and an adviser to the Allied Domecq Pension Funds and the Kraft UKPension Fund (Trustees). On Lisa's appointment, Andrew Slater retires as a Non-Executive Director. James Barder, Futura's Chief Executive, said: "I am delighted to welcome Lisa toFutura's Board as a Non-Executive Director. Her vast experience of thehealthcare and banking sectors will be of great value in the future developmentof the Company. Also, on behalf of the Company, I would like to express ourgratitude to Andrew for his significant contribution to Futura during the pastfive years and to wish him well for his retirement." For any further information please contact: Futura Medical plcJames Barder, Chief Executive Tel: +44 (0) 1483 685 670mail to: james.barder@futuramedical.co.uk www.futuramedical.co.uk Canaccord Adams Tel: +44 (0) 20 7050 6500Ryan Gaffney / Adria Da Breo For any media enquiries please contact: Buchanan Communications Tel: +44 (0) 020 7466 5000Mark Court / Rebecca Skye Dietrich / Catherine Breen Director disclosures Lisa Arnold currently holds no other company directorships or partnerships. Herprevious directorships or partnerships held in the five years preceding herappointment at Futura Medical are as follows: Previous Directorships Previous PartnershipsRAFT Trustees Limited GALA films There are no other matters to be disclosed in relation to Schedule 2 paragraph(g) and (i) of the AIM Rules. Notes Futura Medical plc Futura Medical is a pharmaceutical group that develops innovative products forconsumer healthcare. The Company is developing a portfolio of products and itsstrategy is to license their manufacture and distribution to majorpharmaceutical and healthcare groups. Futura is based in Guildford, Surrey, and its shares trade on the AIM market ofthe London Stock Exchange. www.futuramedical.co.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
4th Jun 20267:00 amRNSNotice of AGM & availability of Annual Report
1st Jun 20263:30 pmRNSBlock Listing Six Monthly Return
22nd May 202612:06 pmRNSHolding(s) in Company
29th Apr 20267:00 amRNSUnaudited Results for the Year Ended 31 Dec 2025
20th Apr 20267:00 amRNSNotice of Results & Investor Presentation
23rd Mar 20267:00 amRNSPositive Eroxon® & Eroxon® “Intense” HUT results
18th Mar 20267:00 amRNSFormal Grant of US Patent
17th Mar 202611:37 amRNSHolding(s) in Company
20th Feb 20264:06 pmRNSHolding(s) in Company
5th Feb 20267:00 amRNSPatent notice of allowance granted for the US
4th Feb 20267:00 amRNSTrading Update
13th Jan 202612:53 pmRNSHolding(s) in Company
13th Jan 202612:51 pmRNSHolding(s) in Company
12th Jan 20267:00 amRNSResults of WSD4000 Early Feasibility Study
7th Jan 20264:34 pmRNSNotification of major holdings
31st Dec 20257:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
30th Dec 20255:31 pmRNSNotification of major holdings
30th Dec 20255:31 pmRNSNotification of major holdings
23rd Dec 20254:37 pmRNSNotification of major holdings
23rd Dec 20254:37 pmRNSNotification of major holdings
18th Dec 20256:15 pmRNSNotification of major holdings
18th Dec 20256:15 pmRNSNotification of major holdings
18th Dec 20255:41 pmRNSNotification of major holdings
18th Dec 20255:41 pmRNSNotification of major holdings
12th Dec 20254:18 pmRNSNotification of major holdings
10th Dec 202512:01 pmRNSNotification of major holdings
10th Dec 202512:00 pmRNSNotification of major holdings
10th Dec 20257:00 amRNSPatent notice of allowance granted for China
9th Dec 20253:59 pmRNSBlock Listing Six Monthly Return
8th Dec 20251:34 pmRNSNotification of major holdings
8th Dec 202512:18 pmRNSDirectors' / PDMR dealing
4th Dec 20253:43 pmRNSNotification of major holdings
4th Dec 20253:41 pmRNSNotification of major holdings
3rd Dec 20257:00 amRNSBoard change
2nd Dec 202511:27 amRNSResult of General Meeting and Total Voting Rights
14th Nov 20254:40 pmRNSPCA Dealing
13th Nov 20254:35 pmRNSPosting of Circular and Notice of GM
13th Nov 20257:00 amRNSFundraise of £2.75 million
3rd Nov 202511:04 amRNSTotal Voting Rights
30th Sep 20257:00 amRNSResults for the six months ended 30 June 2025
26th Sep 202512:11 pmRNSNotice of Results and Investor Presentation
19th Sep 20257:00 amRNSTrading, Business and Strategic Review Update
29th Aug 20257:00 amRNSTotal Voting Rights
8th Aug 20257:00 amRNSBoard Changes, Business Update & Notice of Results
11th Jul 202511:04 amRNSShare price movement
8th Jul 20257:00 amRNSBoard Changes
20th Jun 20257:00 amRNSResult of AGM
2nd Jun 20253:15 pmRNSBlock Listing Six Monthly Return
27th May 20257:00 amRNSNotice of AGM and availability of Annual Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.